Found 7 matching trials
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease PHASE2 This study seeks to evaluate the safety and efficacy of brazikumab versus p...
Show More Learn More & Join Trial
Ibd CAncer and seRious Infections in France (I-CARE 2) N/A This is a French prospective longitudinal observational multicentre cohort ...
Show More Location
CHU Amiens Picardie
Learn More & Join Trial
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease PHASE2 A Phase 2b study to evaluate the efficacy and safety of brazikumab (MEDI207...
Show More Location
Arizona Arthritis & Rheumatology Research, PLLC
Learn More & Join Trial
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis PHASE2 The present study (D5272C00001/Legacy #3151-201-008) aims to evaluate the e...
Show More Learn More & Join Trial
Open-label Extension Study of Brazikumab in Crohn's Disease PHASE3 The purpose of Study D5271C00002 (Legacy #3150-303-008) is to permit partic...
Show More Learn More & Join Trial
Open-label Extension Study of Brazikumab in Ulcerative Colitis PHASE2 The purpose of this OLE Study D5272C00002 (Legacy #3151-202-008) is to perm...
Show More Learn More & Join Trial
Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants PHASE1 This is a Phase I, single-centre, open-label, parallel-group, single dose s...
Show More Learn More & Join Trial